(SeeNews) - Apr 27, 2012 - US bioscience company Metabolix Inc (NASDAQ:MBLX) said Thursday it had turned to a net profit of USD 28.8 million (EUR 22m) in the first quarter of 2012 from a USD-9.6-million loss a year ago.